journal cover

Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA)

The Prostate

Apr 26, 2006

Soo Ok LeeAllen C Gao

Abstract

Epidemiological studies and prevention trials suggest selenium is a promising preventive agent for prostate cancer. Selenium-containing compounds inhibited the growth of prostate cancer cell lines including androgen sensitive LNCaP and androgen insensitive DU145 and PC3 cells in vitro. ...read more

Mentioned in this Paper

AR protein, human
Therapeutic agent (substance)
Androgen Antagonists
Androgens
House mice
Mice, Nude
Neoplasms
Pharmacology
Therapeutic Agent
Prostatic Neoplasms
Paper Details
References
  • References22
  • Citations42
123
  • References22
  • Citations42
12345

Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA)

The Prostate

Apr 26, 2006

Soo Ok LeeAllen C Gao

PMID: 16637076

DOI: 10.1002/pros.20329

Abstract

Epidemiological studies and prevention trials suggest selenium is a promising preventive agent for prostate cancer. Selenium-containing compounds inhibited the growth of prostate cancer cell lines including androgen sensitive LNCaP and androgen insensitive DU145 and PC3 cells in vitro. ...read more

Mentioned in this Paper

AR protein, human
Therapeutic agent (substance)
Androgen Antagonists
Androgens
House mice
Mice, Nude
Neoplasms
Pharmacology
Therapeutic Agent
Prostatic Neoplasms

Related Papers

Paper Details
References
  • References22
  • Citations42
123
  • References22
  • Citations42
12345
/papers/monomethylated-selenium-inhibits-growth-of-lncap/16637076